EPISODE · Jan 18, 2019 · 35 MIN
Part II of Understanding Multiple Myeloma
Paul Richardson, MD, Dana-Farber Cancer Institute, Boston, MA Recorded on December 28, 2018 The conversation continues with Dr. Richardson in Part II of a two part episode on myeloma by describing the phases of treatment: induction remission therapy, consolidation and maintenance. Dr. Richardson provides an in-depth view of real-world issues patients experience, describes combination drug therapies and new treatments, addresses the clinical benefit of transplant for individual patients and the difference between tandem and autotransplant, and the important role of the multidisciplinary healthcare team.Paul Richardson, MD Clinical Program Leader Director of Clinical Research Jerome Lipper Multiple Myeloma Center Dana-Farber Cancer Institute Boston, MA
NOW PLAYING
Part II of Understanding Multiple Myeloma
No transcript for this episode yet
Similar Episodes
May 4, 2026 ·16m
Apr 27, 2026 ·17m
Apr 13, 2026 ·16m
Apr 6, 2026 ·16m
Mar 30, 2026 ·16m
Mar 23, 2026 ·17m